NUKK — Nukkleus Income Statement
0.000.00%
- $59.18m
- $57.19m
- 10
- 64
- 36
- 29
Annual income statement for Nukkleus, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 September 30th | R2023 September 30th | 2024 December 31st | |
---|---|---|---|
Period Length: | 12 M | 12 M | 3 M |
Source: | 10-K | 10-KT | 10-KT |
Standards: | USG | USG | USG |
Status: | Final | Final | Final |
Revenue | |||
Total Revenue | 21.5 | 0 | 0 |
Cost of Revenue | |||
Gross Profit | -0.661 | — | — |
Selling / General / Administrative Expenses | |||
Depreciation and Amortization | |||
Unusual Expense / Income | |||
Total Operating Expenses | 32.7 | 14.7 | 4.8 |
Operating Profit | -11.1 | -14.7 | -4.8 |
Total Net Non Operating Interest Income / Expense | |||
Other Net Non Operating Costs | |||
Net Income Before Taxes | -11.8 | -14.7 | -161 |
Provision for Income Taxes | |||
Net Income After Taxes | -11.8 | -14.7 | -161 |
Net Income Before Extraordinary Items | |||
Extraordinary Items | |||
Net Income | -11.8 | -17.4 | -161 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||
Income Available to Common Shareholders Including Extraordinary Items | |||
Diluted Net Income | -11.8 | -17.4 | -161 |
Diluted Weighted Average Shares | |||
Basic EPS Including Extraordinary Items | |||
Diluted EPS Including Extraordinary Items | |||
Diluted EPS Excluding Extraordinary Items | |||
Normalised Income Before Taxes | |||
Normalised Income After Taxes | |||
Normalised Income Available to Common Shareholders | |||
Diluted Normalised EPS | -4.34 | -2.18 | -51.8 |
Dividends per Share |